Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature
JP Rajan, NE Wineinger, DD Stevenson… - Journal of Allergy and …, 2015 - Elsevier
Background Aspirin-exacerbated respiratory disease (AERD) is manifested by adult-onset
asthma, nasal polyposis, chronic rhinosinusitis, and aspirin sensitivity. Previously reported …
asthma, nasal polyposis, chronic rhinosinusitis, and aspirin sensitivity. Previously reported …
Severe adult asthmas: integrating clinical features, biology, and therapeutics to improve outcomes
SE Wenzel - American journal of respiratory and critical care …, 2021 - atsjournals.org
Evaluation and effective management of asthma, and in particular severe asthma, remains
at the core of pulmonary practice. Over the last 20–30 years, there has been increasing …
at the core of pulmonary practice. Over the last 20–30 years, there has been increasing …
Asthma: from bronchoconstriction to airways inflammation and remodeling
J Bousquet, PK Jeffery, WW Busse… - American journal of …, 2000 - atsjournals.org
Asthma | From Bronchoconstriction to Airways Inflammation and Remodeling | American
Journal of Respiratory and Critical Care Medicine ATS Journals Logo Official Publications …
Journal of Respiratory and Critical Care Medicine ATS Journals Logo Official Publications …
Asthma outcomes: biomarkers
BACKGROUND: Measurement of biomarkers has been incorporated within clinical research
studies of asthma to characterize the population and associate the disease with …
studies of asthma to characterize the population and associate the disease with …
The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the …
WW Stevens, E Jerschow, AP Baptist, L Borish… - Journal of Allergy and …, 2021 - Elsevier
Aspirin-exacerbated respiratory disease (AERD) is characterized by the clinical triad of
chronic rhinosinusitis with nasal polyps, asthma, and an intolerance to medications that …
chronic rhinosinusitis with nasal polyps, asthma, and an intolerance to medications that …
Treatment of asthma with drugs modifying the leukotriene pathway
In 1979 and 1980, the chemical structures of the material previously known as slow-reacting
substance of anaphylaxis were elucidated as 5 (S)-hydroxy-6 (R)-glutathionyl-7, 9-trans-11 …
substance of anaphylaxis were elucidated as 5 (S)-hydroxy-6 (R)-glutathionyl-7, 9-trans-11 …
[图书][B] Middleton's allergy E-Book: Principles and practice
NF Adkinson Jr, BS Bochner, AW Burks, WW Busse… - 2013 - books.google.com
This best-selling resource has a worldwide reputation as the leader in its field. Focusing on
human immunology and biology, while also reporting on scientific experimentation and …
human immunology and biology, while also reporting on scientific experimentation and …
Proinflammatory pathways in the pathogenesis of asthma
RS Peebles, MA Aronica - Clinics in chest medicine, 2019 - chestmed.theclinics.com
The most recent Guidelines for the Diagnosis and Management of Asthma from the National
Asthma Education and Prevention Program define the disease as follows:“Asthma is a …
Asthma Education and Prevention Program define the disease as follows:“Asthma is a …
The role of leukotrienes in inflammation
WR Henderson - Annals of internal medicine, 1994 - acpjournals.org
Objective: To review the biochemistry and biological activities of leukotrienes, focusing on
their role in the mediation of inflammatory diseases. Data Sources: MEDLINE (1966-1994) …
their role in the mediation of inflammatory diseases. Data Sources: MEDLINE (1966-1994) …
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.
AS Cowburn, K Sladek, J Soja… - The Journal of …, 1998 - Am Soc Clin Investig
Aspirin causes bronchoconstriction in aspirin-intolerant asthma (AIA) patients by triggering
cysteinyl-leukotriene (cys-LT) production, probably by removing PGE2-dependent inhibition …
cysteinyl-leukotriene (cys-LT) production, probably by removing PGE2-dependent inhibition …